SCHEMBL9753347

SCHEMBL9753347

CCOC(=O)c1c(-c2ccc(F)c(Cl)c2)nn2cccc2c1C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.43
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPA Q15257 1/20 0.43
EGFR P00533 2/20 0.42
TEAD2 Q15562 1/20 0.41
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
RXFP1 Q9HBX9 1/20 0.40
GAA P10253 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NR3C2 P08235 1/20 0.36
PDE4B Q07343 1/20 0.36
PKM P14618 1/20 0.36
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9753377 0.91 EGFR (0.44) EGFRKDM4EALDH1A1HPGDMEN1
SCHEMBL27438905 0.86 RORC (0.38) EGFRALDH1A1MEN1KMT2ANPSR1
SCHEMBL9752865 0.86 ALDH1A1 (0.49) PTPN1EGFRKDM4EALDH1A1HPGD
SCHEMBL9753208 0.83 CDC7 (0.44) EGFRKDM4EALDH1A1HPGDMEN1
SCHEMBL9753865 0.83 EGFR (0.59) EGFRKDM4EALDH1A1HPGDMEN1
SCHEMBL9752829 0.81 ALDH1A1 (0.44) EGFRKDM4EALDH1A1HPGDMEN1
SCHEMBL9753002 0.79 TGFBR1 (0.36) EGFRGRIN1GRIN2BMDM2
SCHEMBL5093057 0.78 ALDH1A1 (0.52) EGFRKDM4EALDH1A1HPGDMEN1
SCHEMBL9753040 0.77 PTGS2 (0.36) EGFRKDM4EALDH1A1GAAL3MBTL1
SCHEMBL9753668 0.75 GRM6 (0.41) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991018903-A1 PYRROLOPYRIDAZINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-12-12 WO disclosed